Literature DB >> 3740035

Incidence of cervical cancer following negative smear. A cohort study from Maribo County, Denmark.

E Lynge, P Poll.   

Abstract

In order to estimate the risk of developing cervical cancer among women who originally had cytologically normal Papanicolaou (Pap) smears, information has been collected on all Pap smears taken in Maribo County, Denmark in 1966-1982 among women born 1918-1952. A total of 27,811 women are included in the study, and cases of invasive cervical cancer developed in the study population have been identified from the local department of pathology and from the Danish Cancer Registry. The incidence of cervical cancer has been tabulated by number of previous negative smears and by time elapsed since last negative smear. Women with one previous negative smear have a zero risk of developing cervical cancer during the first year following the negative smear. The incidence among these women increases with length of time since the negative smear and reaches the level of unscreened women during the fifth year of follow-up. Women with 2-4 previous negative smears also have a negligible risk of developing cervical cancer during the first two years following the last negative smear. The incidence among these women increases less over time than the incidence for women with one previous negative smear. No cases of cervical cancer were observed among 7,716 women with 5+ previous negative smears. The study indicates that the 5-year risk of developing cervical cancer is 48% lower in women with one previous negative smear than in an unselected population of unscreened women. The 5-year risk for women with 2-4 previous negative smears is 69% lower than that for unscreened women.

Entities:  

Mesh:

Year:  1986        PMID: 3740035     DOI: 10.1093/oxfordjournals.aje.a114404

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  5 in total

1.  Non-progression of cervical intraepithelial neoplasia estimated from population-screening data.

Authors:  A B Bos; M van Ballegooijen; G J van Oortmarssen; M E van Marle; J D Habbema; E Lynge
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  A centralised cytology screening programme for cervical cancer in Florence.

Authors:  D Palli; S Carli; S Cecchini; A Venturini; G Piazzesi; E Buiatti
Journal:  J Epidemiol Community Health       Date:  1990-03       Impact factor: 3.710

3.  Measuring progress against cancer.

Authors:  H Møller; A Mellemgaard; O M Jensen
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 4.  Screening for cancer of the cervix uteri.

Authors:  E Lynge
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

5.  Smear misclassification in a cervical cancer screening programme.

Authors:  E Lynge; E Arffmann; P Poll; P K Anderson
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.